Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Oracle (ORCL-PD) Cash & Equivalents (2016 - 2026)

Oracle filings provide 18 years of Cash & Equivalents readings, the most recent being $38.5 billion for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 120.93% to $38.5 billion in Q1 2026 year-over-year; TTM through Feb 2026 was $38.5 billion, a 120.93% increase, with the full-year FY2025 number at $10.8 billion, up 3.18% from a year prior.
  • Cash & Equivalents hit $38.5 billion in Q1 2026 for Oracle, up from $19.2 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $38.5 billion in Q1 2026 to a low of $6.8 billion in Q4 2022.
  • Median Cash & Equivalents over the past 5 years was $10.6 billion (2024), compared with a mean of $13.9 billion.
  • Biggest five-year swings in Cash & Equivalents: plummeted 63.76% in 2023 and later soared 120.93% in 2026.
  • Oracle's Cash & Equivalents stood at $6.8 billion in 2022, then grew by 21.0% to $8.2 billion in 2023, then soared by 32.71% to $10.9 billion in 2024, then surged by 75.86% to $19.2 billion in 2025, then surged by 99.86% to $38.5 billion in 2026.
  • The last three reported values for Cash & Equivalents were $38.5 billion (Q1 2026), $19.2 billion (Q4 2025), and $10.4 billion (Q3 2025) per Business Quant data.